Paper Details

  1. Home
  2. Paper Details

Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis.

Author: BrigdenGrania, CookeGraham, CoxHelen, DeyTeesta, FordNathan, ShubberZara

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Clofazimine, when used in combination therapy, shows promise as an additional therapeutic option for the treatment of drug-resistant tuberculosis (DR-TB). However, the optimal dose and duration of clofazimine use require further investigation.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Current anti-tuberculosis therapeutics are not sufficiently effective against drug-resistant tuberculosis (DR-TB), and there is a need for new drugs and therapeutic approaches. It has been proposed that repurposing clofazimine for DR-TB treatment might be one way to increase therapeutic ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/jac/dks389

データ提供：米国国立医学図書館（NLM）

Clofazimine: A New Weapon Against Drug-Resistant Tuberculosis

Tuberculosis, a disease that has plagued humanity for centuries, has become increasingly challenging to treat due to the emergence of drug-resistant strains. This research explores the potential of clofazimine, a repurposed drug, as a possible treatment option for drug-resistant tuberculosis. They conducted a systematic review of existing studies to assess the efficacy and safety of clofazimine in treating this dangerous infection. Their findings suggest that clofazimine could be a valuable tool for combating drug-resistant tuberculosis.

A Renewed Hope in the Fight Against Tuberculosis

The review of 12 studies involving over 3400 patients revealed that clofazimine, when used in combination therapy, showed promising results in treating drug-resistant tuberculosis. The pooled treatment success rate was 61.96%, indicating a significant potential for this drug. These findings suggest that clofazimine could be a crucial weapon in the fight against this deadly disease.

A More Effective Treatment for Tuberculosis

For patients suffering from drug-resistant tuberculosis, a lack of effective treatment options has been a major concern. This research could lead to a more effective treatment regimen, potentially reducing the burden of this disease and improving patient outcomes. This could be a turning point in the fight against tuberculosis, offering new hope to those struggling with this devastating illness.

Dr.Camel's Conclusion

Drug-resistant tuberculosis is a formidable foe, like a relentless sandstorm that seems impossible to escape. This research offers a glimmer of hope by exploring the potential of clofazimine as a new weapon against this disease. It could be a crucial breakthrough, providing a lifeline to patients seeking relief from this devastating illness.

Date :
  1. Date Completed 2013-06-10
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

23054996

DOI: Digital Object Identifier

10.1093/jac/dks389

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.